TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10248151

Group type: COMPARATOR
Intervention: Information booklet provided to patients on the experimental ward and control ward.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nondirective therapeutic skills training for staff nurses on the experimental ward.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive and informative talk with a trained nurse on the experimental ward.
Number of subjects: 0
Study: 30519955

Group type: EXPERIMENTAL
Intervention: External cold and a vibrating device
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control intervention (1.8 ml of 2% lidocaine with 1:100,000 adrenaline)
Number of subjects: 60
Study: 28017199

Group type: EXPERIMENTAL
Intervention: Active left DLPFC stimulation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Active right PPC stimulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 10
Study: 26260081

Group type: EXPERIMENTAL
Intervention: Cannabis use disorder (CUD)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Recency of cannabis use
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Frequency of cannabis use
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Dose of cannabis consumption
Number of subjects: 133
Study: 23828291

Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 19
Study: 21957588

Group type: EXPERIMENTAL
Intervention: Thymogen preparation administered by intranasal instillation of 100 mg once a day for 7 days before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution (placebo) administered in the same scheme
Number of subjects: 0
Study: 19703279

Group type: EXPERIMENTAL
Intervention: Oxytocin 5 IU bolus and 40 IU infusion
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Oxytocin 5 IU bolus and placebo infusion
Number of subjects: 2000
Study: 17367495

Group type: EXPERIMENTAL
Intervention: CHF 4227 (5-400 mg single doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CHF 4227 (5-100 mg multiple doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CHF 4227 (5 and 10 mg)
Number of subjects: 100
Study: 14702440

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated) at 24 micro g/kg per hour for 96 hours (part 2)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Drotrecogin alfa (activated) at escalating doses of 6, 12, 24, and 36 micro g/kg per hour for 6 hours (part 1)
Number of subjects: 83
Study: 11736869

Group type: EXPERIMENTAL
Intervention: Alosetron 1 mg twice daily for 15 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Theophylline 200 mg twice daily alone for 8 days
Number of subjects: 10
Study: 9243685

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg.kg‐1
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diazepam 0.25 mg.kg‐1 with droperidol 0.25 mg.kg‐1
Number of subjects: 90

Group type: COMPARATOR
Intervention: Trimeprazine 2 mg.kg‐1
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Midazolam or diazepam‐droperidol
Number of subjects: 90
Study: 8301808

Group type: EXPERIMENTAL
Intervention: GI priming with mother's milk (n = 7)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Total parenteral nutrition alone (n = 21)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: GI priming with infant formula (n = 19)
Number of subjects: 47
Study: 3718367

Group type: EXPERIMENTAL
Intervention: Oral fenoterol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral salbutamol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31094260

Group type: EXPERIMENTAL
Intervention: HAW (water ad libitum)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heat acclimation
Number of subjects: 20

Group type: COMPARATOR
Intervention: HANW (no fluid allowed)
Number of subjects: 20
Study: 31462990

Group type: EXPERIMENTAL
Intervention: Chiropractic manipulation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 200
Study: 28460597

Group type: EXPERIMENTAL
Intervention: Active Ankle Foot Orthosis (AFO)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inactive Ankle Foot Orthosis (AFO)
Number of subjects: 10
Study: 26545272

Group type: EXPERIMENTAL
Intervention: Boil-and-bite (BB) mouthpiece
Number of subjects: 16

Group type: COMPARATOR
Intervention: No mouthpiece (NM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ethylene vinyl acetate (EVA) custom mandibular mouthpiece
Number of subjects: 16

Group type: COMPARATOR
Intervention: Polypropylene (Poly) custom mandibular mouthpiece
Number of subjects: 16
Study: 23620935

Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion with spontaneous heating bags, applied for 12 hours once a day.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medicine (smectite powder and live combined bifidobacterium and lactobacillus tablets), orally administered.
Number of subjects: 120
Study: 21623600

Group type: EXPERIMENTAL
Intervention: sulodexide 75 mg daily
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: sulodexide 150 mg daily
Number of subjects: 77

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 77
Study: 19458014

Group type: EXPERIMENTAL
Intervention: Medicinal iron (n = 48)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Iron-fortified cereal (n = 45)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (n = 59)
Number of subjects: 152
Study: 16446376

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate 2000/125 mg twice daily
Number of subjects: 566

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 875/125 mg three times daily
Number of subjects: 566
Study: 15153926

Group type: EXPERIMENTAL
Intervention: Educational feedback intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 37
Study: 11897014

Group type: EXPERIMENTAL
Intervention: Structured, one-time tobacco-use prevention intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Comparison groups (Groups 2 and 3)
Number of subjects: 28
Study: 9834042

Group type: EXPERIMENTAL
Intervention: 10-minute intravenous infusion of 5 microg x kg(‐1) hCRF
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 180-minute intravenous infusion of 5 microg x kg(‐1) hCRF
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of hCRF (300, 600, or 1200 microg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Repetitive administration of hCRF
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Relationship between plasma hCRF concentrations and heart rate increase
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Relationship between plasma hCRF concentrations and diastolic blood pressure
Number of subjects: 24
Study: 8077989

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX) and fluorouracil (FU)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX) and fluorouracil (FU) with a 6-hour interval
Number of subjects: 101
Study: 2685451

Group type: EXPERIMENTAL
Intervention: Timolol (Chibro‐Timoptol 0.5%)
Number of subjects: 20
Study: 49736

Group type: EXPERIMENTAL
Intervention: Propranolol (0-1 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Practolol (1 mg/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acebutolol (1 mg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31660894

Group type: EXPERIMENTAL
Intervention: 3D conformal radiotherapy (VMAT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Simple unplanned palliative radiotherapy (SUPR)
Number of subjects: 250
Study: 28865924

Group type: EXPERIMENTAL
Intervention: 55.8 Gy (RBE) of fractionated combined proton-photon radiation therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: 63.0 Gy (RBE) of fractionated combined proton-photon radiation therapy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both doses (55.8 Gy and 63.0 Gy)
Number of subjects: 44
Study: 26047682

Group type: EXPERIMENTAL
Intervention: Supervised aerobic and resistance training plus structured exercise counseling (EXE)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Counseling alone (CON)
Number of subjects: 606
Study: 23500281

Group type: EXPERIMENTAL
Intervention: COURAGE
Number of subjects: 5034

Group type: EXPERIMENTAL
Intervention: BARI 2D
Number of subjects: 5034

Group type: EXPERIMENTAL
Intervention: FREEDOM
Number of subjects: 5034
Study: 21802303

Group type: EXPERIMENTAL
Intervention: Concurrent cognitive task (silent backward counting)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Single tasking
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dual tasking
Number of subjects: 23
Study: 19374676

Group type: EXPERIMENTAL
Intervention: Nasal cannulae (5 L/minute)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Oxygen mask (5 L/minute)
Number of subjects: 106
Study: 16675091

Group type: EXPERIMENTAL
Intervention: Aceclofenac 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14586587

Group type: EXPERIMENTAL
Intervention: Intermittent running tests to exhaustion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Continuous running protocol
Number of subjects: 6
Study: 10961730

Group type: EXPERIMENTAL
Intervention: mesalamine 1 g two times a day plus Saccharomyces boulardii 1 g daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: mesalamine 1 g three times a day
Number of subjects: 32
Study: 8774552

Group type: EXPERIMENTAL
Intervention: Dynamic training program
Number of subjects: 54

Group type: COMPARATOR
Intervention: Relaxation training program
Number of subjects: 54

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 54
Study: 1611155

Group type: EXPERIMENTAL
Intervention: Glyburide 10 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6375991

Group type: EXPERIMENTAL
Intervention: Manual suture (Group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Planned stapler suture (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Withdrawn cases (Group WD)
Number of subjects: 0
Study: 30907198

Group type: EXPERIMENTAL
Intervention: Diet intervention
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Weight loss ≥5.0 percent
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Diet group
Number of subjects: 55
Study: 30266264

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 28394002

Group type: EXPERIMENTAL
Intervention: 1 g of omega-3 acids daily for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (corn oil 1 g daily for 12 weeks)
Number of subjects: 30
Study: 25990625

Group type: EXPERIMENTAL
Intervention: redDAP group
Number of subjects: 206

Group type: COMPARATOR
Intervention: SG group
Number of subjects: 206
Study: 23046851

Group type: EXPERIMENTAL
Intervention: Oral methamphetamine (0, 8 or 16 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Alternative reinforcer ($0.25)
Number of subjects: 7
Study: 21944180

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 162
Study: 19364887

Group type: EXPERIMENTAL
Intervention: Debridement of type II SLAP lesions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Repair of type II SLAP lesions
Number of subjects: 48
Study: 16740174

Group type: EXPERIMENTAL
Intervention: PV measurement using the constant flow method (PVCF); insufflated volume = 1120 +/- 115 ml, plateau pressure = 46 +/- 11 cmH2O
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: PV measurement using a 2 l super syringe (PVSS); insufflated volume = 1824 +/- 381 ml, plateau pressure = 46 +/- 9 cmH2O
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control period (no PV measurement)
Number of subjects: 17
Study: 15356367

Group type: EXPERIMENTAL
Intervention: Antimicrobial wound cleanser (0.057% sodium hypochlorite in isotonic saline solution)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Antimicrobial wound cleanser
Number of subjects: 18
Study: 10699770

Group type: EXPERIMENTAL
Intervention: Inhaled Entonox (50% nitrous oxide, 50% oxygen)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Intravenous midazolam and meperidine
Number of subjects: 102
Study: 9432334

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole once in the morning, 200 mg clarithromycin twice daily, and 250 mg metronidazole twice daily for 1 week (LCM1)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole once in the morning, 200 mg clarithromycin twice daily, and 500 mg metronidazole twice daily for 1 week (LCM2)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: LCM1
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: LCM2
Number of subjects: 104
Study: 1402359

Group type: EXPERIMENTAL
Intervention: 15% silver nitrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5% to 25% silver nitrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 0
Study: 3841333

Group type: EXPERIMENTAL
Intervention: 3 or 6 cycles of MOPP followed by Mantle field with or without mediastinal irradiation and/or inverted Y or lumboaortic field
Number of subjects: 334

Group type: COMPARATOR
Intervention: 6 cycles of MOPP
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: 3 cycles of MOPP followed by irradiation
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: 3 cycles of MOPP and radiotherapy
Number of subjects: 334
Study: 3593624

Group type: EXPERIMENTAL
Intervention: Y-8894 50 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nortriptyline 50 mg
Number of subjects: 18
Study: 31918685

Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by best-corrected visual acuity (BCVA) loss (Group I)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by BCVA loss and/or signs of disease activity on optical coherence tomography (OCT; Group II)
Number of subjects: 671
Study: 30025734

Group type: EXPERIMENTAL
Intervention: USCDT with 4 mg tPA/lung for 2 hours
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: USCDT with 4 mg tPA/lung for 4 hours
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: USCDT with 6 mg tPA/lung for 6 hours
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: USCDT with 12 mg tPA/lung for 6 hours
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: All USCDT groups
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 101
Study: 28279200

Group type: EXPERIMENTAL
Intervention: Book-sharing intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 25786048

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Acetyl L-carnitine 1500 mg/day (500 mg t.i.d.)
Number of subjects: 65
Study: 24064773

Group type: EXPERIMENTAL
Intervention: Calorie-limited diet, physical exercise, and cognitive behavioral training during working hours 1 hour per week
Number of subjects: 144

Group type: COMPARATOR
Intervention: Presentations about healthy lifestyle
Number of subjects: 144
Study: 20332060

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 1260
Study: 18203046

Group type: EXPERIMENTAL
Intervention: 5-HT stimulation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 5-HT stimulation during treatment
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment in patients with depression
Number of subjects: 25
Study: 16365055

Group type: EXPERIMENTAL
Intervention: Betaine 3 g
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Betaine 6 g
Number of subjects: 10

Group type: COMPARATOR
Intervention: Betaine 1 g
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Betaine (all doses)
Number of subjects: 10
Study: 14564940

Group type: EXPERIMENTAL
Intervention: Multi‐micronutrient supplement (S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi‐micronutrient supplement plus test meal (MS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Test meal (M)
Number of subjects: 0
Study: 11186161

Group type: EXPERIMENTAL
Intervention: Cystinosis group
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 141
Study: 8863312

Group type: EXPERIMENTAL
Intervention: Surgical intervention (root-end resection and root-end filling)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional retreatment
Number of subjects: 38
Study: 1735488

Group type: COMPARATOR
Intervention: Single periovulatory intrauterine insemination (IUI)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Double intrauterine insemination (IUI) - one before ovulation and one after ovulation
Number of subjects: 31
Study: 6588726

Group type: EXPERIMENTAL
Intervention: Professional tooth-cleaning plus fluoride mouth-rinsing every 3rd week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoride varnish treatment every 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individualized prevention measures based on estimated needs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Professional tooth-cleaning plus fluoride mouth-rinsing
Number of subjects: 0
Study: 29926431

Group type: EXPERIMENTAL
Intervention: Therapeutic education programme 'PETAL' for laryngectomised patients and their close relations; details on dosage and duration not specified.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pilot phase of the programme; details on dosage and duration not specified.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prospective intervention 'replication' phase; details on dosage and duration not specified.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster-randomised multicentric comparative intervention phase; details on dosage and duration not specified.
Number of subjects: 0
Study: 29144178

Group type: EXPERIMENTAL
Intervention: Evening-dosing of DCF regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morning-dosing of DCF regimen
Number of subjects: 0
Study: 26853293

Group type: EXPERIMENTAL
Intervention: Subepidermal triamcinolone injections (4mg per cc, 5mm intervals until complete blanching)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Kligman's formula (hydroquinone 5%, tretinoin 0.1%, dexamethasone 0.1%)
Number of subjects: 42
Study: 24875781

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 2579

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 2579
Study: 22312173

Group type: EXPERIMENTAL
Intervention: School-wide Positive Behavioral Interventions and Supports (SWPBIS)
Number of subjects: 12344

Group type: COMPARATOR
Intervention: Control group (schools without SWPBIS)
Number of subjects: 12344
Study: 20207720

Group type: EXPERIMENTAL
Intervention: 100% of the RDA for SAA, 15 mg/kg APAP given on day 3
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0% of the RDA for SAA, 15 mg/kg APAP given on day 3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100% of the RDA for SAA, placebo given on day 3
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0% of the RDA for SAA, placebo given on day 3
Number of subjects: 0
Study: 18687168

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam and Propofol combination
Number of subjects: 60
Study: 16019883

Group type: EXPERIMENTAL
Intervention: Desktop text telephones with direct connection
Number of subjects: 28

Group type: COMPARATOR
Intervention: Desktop text telephones with acoustic connection
Number of subjects: 28
Study: 11571734

Group type: EXPERIMENTAL
Intervention: Groshong catheter (experimental group)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Open-ended catheter (control group)
Number of subjects: 304
Study: 9590466

Group type: COMPARATOR
Intervention: KA 672-HCl 40 mg single dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: KA 672-HCl 60 mg single dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: KA 672-HCl 10 mg repeated doses for 14 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: KA 672-HCl 20 mg repeated doses for 14 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: KA 672-HCl repeated doses
Number of subjects: 100

Group type: COMPARATOR
Intervention: KA 672-HCl single dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: KA 672-HCl 20 mg single dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: KA 672-HCl 20 mg repeated doses
Number of subjects: 100
Study: 8072816

Group type: EXPERIMENTAL
Intervention: DTP-IPV-PRPT
Number of subjects: 161

Group type: COMPARATOR
Intervention: DTP-IPV-placebo
Number of subjects: 161
Study: 3384164

Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanic acid (2.2 g preoperative dose)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Cefuroxim (1.5 g) combined with Metronidazole (0.5 g)
Number of subjects: 251
Study: 31010007

Group type: EXPERIMENTAL
Intervention: CIPA nutrition screening and treatment
Number of subjects: 412

Group type: COMPARATOR
Intervention: Standard clinical care
Number of subjects: 412
Study: 28706176

Group type: EXPERIMENTAL
Intervention: Memory and visual-motor integration program (12 sessions over 6 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 26488155

Group type: EXPERIMENTAL
Intervention: SYSTANE BALANCE Lubricant Eye Drops (n=76)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Habitual nonlipid contact lens rewetting eye drop (n=30)
Number of subjects: 106
Study: 24120754

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) programme, trained twice a week for 10 weeks at a community gymnasium with a physiotherapy student mentor using pin-loaded weight machines
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) programme
Number of subjects: 68

Group type: COMPARATOR
Intervention: Social group (control), completed a 10-week programme of social activities once a week for 90 min with a student mentor
Number of subjects: 68
Study: 21046372

Group type: EXPERIMENTAL
Intervention: Phaffia rhodozyma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haematococcus pluvialis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemical synthesis
Number of subjects: 0